Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiahua Pan

Showing results (91-100 of 142) with videos related to

Pageof 15
Sort By:
Current Oncology (Toronto, Ont.)|September 22, 2022
The Diagnostic Value of PI-RADS v2.1 in Patients with a History of Transurethral Resection of the Prostate (TURP)Jiazhou Liu, Shihang Pan, Liang Dong, et al.
International Journal of Nanomedicine|April 12, 2022
Surface-Enhanced Raman Spectroscopy of Pretreated Plasma Samples Predicts Disease Recurrence in Muscle-Invasive Bladder Cancer Patients Undergoing Neoadjuvant Chemotherapy and Radical CystectomyHongyang Qian, Yiqiu Wang, Zehua Ma, et al.
Nature Communications|March 24, 2026
Spatiotemporally engineered tumor-derived extracellular vesicle-based scaffold vaccine for personalized cancer immunotherapyQi Chen, Chenwei Jiang, Xinxing Du, et al.
Therapeutic Advances in Respiratory Disease|February 5, 2021
CARE: an observational study of adherence to home nebulizer therapy among children with asthmaDeyu Zhao, Dehui Chen, Ling Li, et al.
American Journal of Cancer Research|January 8, 2021
Downregulation of circ-TRPS1 suppressed prostatic cancer prognoses by regulating miR-124-3p/EZH2 axis-mediated stemnessJianjun Sha, Lei Xia, Qing Han, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 28, 2020
Deep convolutional neural networks combine Raman spectral signature of serum for prostate cancer bone metastases screeningXiaoguang Shao, Heng Zhang, Yanqing Wang, et al.
Medical Oncology (Northwood, London, England)|September 13, 2020
Prospective evaluation of <sup>68</sup>Ga-PSMA-11 PET/CT in Chinese men with biochemical recurrence after radical prostatectomy for prostate cancer: relationships between location of recurrence, time after prostatectomy, and serum PSA levelLiang Dong, Yinjie Zhu, Mei Xin, et al.
Urologic Oncology|August 31, 2019
Neoadjuvant chemohormonal therapy combined with radical prostatectomy and extended PLND for very high risk locally advanced prostate cancer: A retrospective comparative studyJiahua Pan, Chenfei Chi, Hongyang Qian, et al.
The Journal of Urology|April 27, 2021
Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous RecombinationLiancheng Fan, Xiaochen Fei, Yinjie Zhu, et al.
BMC Cancer|May 26, 2016
Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapyYanqing Wang, Fan Xu, Jiahua Pan, et al.
Pageof 15

Showing results (91-100 of 142) with videos related to

Sort By:
Pageof 15
Current Oncology (Toronto, Ont.)|September 22, 2022
The Diagnostic Value of PI-RADS v2.1 in Patients with a History of Transurethral Resection of the Prostate (TURP)Jiazhou Liu, Shihang Pan, Liang Dong, et al.
International Journal of Nanomedicine|April 12, 2022
Surface-Enhanced Raman Spectroscopy of Pretreated Plasma Samples Predicts Disease Recurrence in Muscle-Invasive Bladder Cancer Patients Undergoing Neoadjuvant Chemotherapy and Radical CystectomyHongyang Qian, Yiqiu Wang, Zehua Ma, et al.
Nature Communications|March 24, 2026
Spatiotemporally engineered tumor-derived extracellular vesicle-based scaffold vaccine for personalized cancer immunotherapyQi Chen, Chenwei Jiang, Xinxing Du, et al.
Therapeutic Advances in Respiratory Disease|February 5, 2021
CARE: an observational study of adherence to home nebulizer therapy among children with asthmaDeyu Zhao, Dehui Chen, Ling Li, et al.
American Journal of Cancer Research|January 8, 2021
Downregulation of circ-TRPS1 suppressed prostatic cancer prognoses by regulating miR-124-3p/EZH2 axis-mediated stemnessJianjun Sha, Lei Xia, Qing Han, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 28, 2020
Deep convolutional neural networks combine Raman spectral signature of serum for prostate cancer bone metastases screeningXiaoguang Shao, Heng Zhang, Yanqing Wang, et al.
Medical Oncology (Northwood, London, England)|September 13, 2020
Prospective evaluation of <sup>68</sup>Ga-PSMA-11 PET/CT in Chinese men with biochemical recurrence after radical prostatectomy for prostate cancer: relationships between location of recurrence, time after prostatectomy, and serum PSA levelLiang Dong, Yinjie Zhu, Mei Xin, et al.
Urologic Oncology|August 31, 2019
Neoadjuvant chemohormonal therapy combined with radical prostatectomy and extended PLND for very high risk locally advanced prostate cancer: A retrospective comparative studyJiahua Pan, Chenfei Chi, Hongyang Qian, et al.
The Journal of Urology|April 27, 2021
Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous RecombinationLiancheng Fan, Xiaochen Fei, Yinjie Zhu, et al.
BMC Cancer|May 26, 2016
Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapyYanqing Wang, Fan Xu, Jiahua Pan, et al.
Pageof 15